(2S)-2-(4-(1-(2-Amino-4-hydroxypteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioic Acid
- CAS
- 1548618-61-6
- Formula
- C23H22N6O6
- MW
- 478.5 g/mol
VQ-027562
Impurity reference standards
Pralatrexate impurities & reference standards
Characterised Pralatrexate impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
13reference materials
COAHPLC · NMR · MS on request
(4-(2-(2,4-Diaminopteridin-6-yl)ethyl)benzoyl)glutamic Acid
- CAS
- 309722-11-0
- Formula
- C20H21N7O5
- MW
- 439.4 g/mol
VQ-045086
(4-(2-(2,4-Diaminopteridin-7-yl)ethyl)benzoyl)glutamic Acid
- CAS
- 2058054-07-0
- Formula
- C20H21N7O5
- MW
- 439.4 g/mol
VQ-033263
4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzoic Acid
- CAS
- 146464-93-9
- Formula
- C18H16N6O2
- MW
- 348.4 g/mol
VQ-027563
FAQs — Pralatrexate impurities
Which Pralatrexate impurities do you supply?
We list 13 Pralatrexate-related reference materials, including process impurities, degradation products and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Pralatrexate impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Pralatrexate impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Pralatrexate impurity standards
We reply within one business day with price, pack options, lead time and documentation.